ABSTRACT: A new type of amphiphilic chitosan, which was synthesized through the use of both hydrophilic carboxymethyl and hydrophobic hexanoyl substitutions, was employed to self-assemble into a hollow nanocapsule in an aqueous environment. Critical aggregation concentration (cac) and zeta potential were experimentally identified for the amphiphilic chitosan (CHC). Both experimental data suggested that the self-assembly behavior of the CHC is fundamentally determined as an interplay between the hydrophobic interaction and the variation of the zeta potential upon hexanoyl substitution, which further influenced the nanostructural evolution of the nanocapsules. Higher hexanoyl substitution promoted larger nanocapsules, ca. 200 nm in diameter, while a reduced zeta potential was correspondingly detected, and vice versa, forming smaller nanocapsules, ca. 20 nm in diameter. The selfassemble mechanism, together with the corresponding nanostructural stability, of this unique CHC nanocapsule was also proposed in terms of intermolecular interaction and thermodynamic reason. By taking the advantage of the self-assemble (or self-aggregation) capability, the CHC was employed for drug encapsulation, i.e., doxorubicin, an anticancer molecule; we found in this preliminary evaluation that it reached an efficiency of 46.8%, and a corresponding drug release from the nanocapsules for a time period exceeded 7 days can be achieved in vitro.
Introduction
Nanotechnology has received the greatest attention because of its potential that can literally revolutionize each field in which it is being exploited. The importance of nanotechnology in drug delivery is in the concept and ability to manipulate molecules and supramolecular structures for producing devices with programmed functions. In biotechnology and medicine, by controlling the composition, structure, and function of the nanosized polymer materials, such as nanoparticles, 1 micelles, 2 and nanocapsules, 3 they can serve as effective vehicles for drug delivery, drug controlled release, and gene therapy. Compared to nanoparticle (monolithic-type device), hollow nanocapsules (reservoir-type device) have been attracting increasing interest because of their potential ability to encapsulate large quantities of therapeutic and diagnostic agents in their hollow inner cavities and release them at a later stage in a controlled manner. Even though several different routes, such as layer-by-layer deposition of polyelectrolytes onto a template core, 4 microemulsion polymerization, 5 and self-assembly of block copolymers in a selective solvent, 6 have been successfully developed, these strategies require the templates to be removed to create a hollow interior or need greater quantities of surfactants to form nanosized micelles. Furthermore, most of the hollow nanocapsules described to date are ill-suited for biomedical application, and the lack of biocompatibility and degradability is of another important concern. Therefore, the use of natural polymer with properties desirable for many practical considerations in the field of biomedicals is of most interest.
As was well recognized, chitosan (CS), -(1,4)-link glucosamine unit, is produced by deacetylation of chitin, which is extracted from the shells of crabs, shrimp, and krill. It exhibits several characteristics such as biocompatibility, nontoxicity, and bioadhesivity which make it as an ideal material for biomedical uses, such as drug delivery. 7 However, its poor solubility in water and common organic solvents has so far limited its widespread utilization. The reactive amino groups in the backbone of chitosan make it possible to chemically conjugate with various biological molecules. 8 As a result, there have been many works about the methods to enhance the solubility of chitosan, one of which was derivatization. For example, the introduction of carboxyl groups to chitosan derivatives led to the anionic or amphotheric properties, are water-soluble, and are attracting much attention as metal collecting materials and biomaterials. 9 Hence, hydrophilically, 10 hydrophobically, 11 and amphiphilically 12 modified chitosan derivatives are being studied to form the monodisperse self-aggregated nanoparticles by sonication in aqueous media due to noncovalent association arising from intra-or/and intermolecular interactions among hydrophobic segments in aqueous media. However, in these studies, the formation of hollow structure is more difficult than that of particle structure.
In this study, a new type of chitosan hollow structure, i.e., carboxymethyl-hexanoyl chitosan (CHC), which was modified first by hydrophilic carboxymethylation to increase the flexibility of chitosan molecular chains in water 13 followed by hydrophobic modification with hexanoyl groups to add amphiphilic character, was employed to study its self-aggregation behavior to form nanocapsule in aqueous solution and nanostructural evolution. The stability of nancapsules and formation mechanism of the CHC macromolecules were explored through the use of critical aggregation concentration (cac), zeta potential, electron microscopy, and dynamic light scatter (DLS). By taking the advantage of self-aggregation nature, the CHC was employed to encapsulate doxorubicin (DOX), an anticancer agent of broad spectrum with reasonable therapeutic index and intriguing biological and physicochemical actions, 14 to further understand its loading efficiency and release behavior.
Experimental Section
2.1. Materials. Chitosan (M w ) 215 000 g/mol, deacetylation degree ) 85-90%) was supplied from Aldrich-Sigma. 2-Propanol, sodium hydroxide, chloroacetic acid, and hexanoyl anhydride were purchased from Sigma Co. All other chemical reagents in the study were analytical grade.
2.2. Synthesis of CHC. According to our previous report, 15 CHC can be successfully prepared through following steps. Briefly, 5 g of chitosan was suspended in 2-propanol (50 mL) at room temperature while being stirred for 30 min. The resulting suspension was gently mixed with 12.5 mL of NaOH solution. The mixture containing NaOH of 13.3 M was mixed with 25 g of chloroacetic acid to prepare carboxymethyl chitosan (CC) sample with a high degree of carboxymethyl substitution. The obtained and dried sample (2 g) was dissolved in distilled water (50 mL) while being stirred for 24 h. These resulting solutions were mixed with methanol (50 mL), followed by the addition of hexanoyl anhydride at concentration of 0.2, 0.3, 0.4, and 0.5 M for the CHC samples with different degrees of hexanoyl substitution. After the reaction time of 12 h, the resulting solutions were collected by dialysis membrane (Sigma Chemical Co.) after dialysis with ethanol solution (25% v/v) for 24 h. CHC samples with various degrees of hexanoyl substitution (DH) were named and are shown in Table 1 . The sites and degrees of substitution were confirmed by 1 H NMR analysis in pervious work. 
Preparation of CHC Hollow Nanocapsules.
A 100 mg/ mL CHC sample was suspended in distilled water under gentle shaking at 25°C for 24 h, followed by ultrasonication using a probe type sonifier (Automatic Ultrasonic Processor UH-500A, China) at 30 W for 2 min. The sonication was repeated three times to get an optically clear solution. To inhibit the heat buildup during sonication, the pulse function was used (pulse on 5.0 s; pulse off 1.0 s).
2.4. Characterization. Zeta potential measurements of the nanocapsules were determined with a Malvern Zreasizer 169 HS3000 photon correlation spectrometer with an applied 170 voltage of 100 V. The mean size and size distribution of the nanocapsules were measured by dynamic light scattering (DLS) nanoparticle size analyzer (LB-550, HORIBA, Japan). All measurements were done with a wavelength of 633.0 nm at 25°C with an angle detection of 90°. Each sample was repeatedly measured three times. Morphological evaluation of the hollow nanocapusles was performed by transmission electron microscopy (TEM) (JEOL2100, Japan) and scanning electron microscopy (SEM) (S6500, JEOL, Japan). Sample solutions were dropped onto the carbon-coated 300 mesh copper grids and dried at 50°C and then examined without being stained for TEM analysis. For SEM observation, sample was suspended into anhydrous ethanol and then dip-coated on the silicon substrate. After evaporation at 50°C for 24 h, dried samples were coated with gold (∼20 nm thickness) for analysis.
2.5. Self-Aggregation Behavior of CHC. The pyrene solution (1.0 × 10 -4 M) in methanol was added into the test tubes and evaporated under a stream of nitrogen gas to remove the solvents. Then, solutions of CHC self-aggregates in distilled water were added into the above test tubes, bringing the final concentration of pyrene to 1.0 × 10 -6 M, which was nearly equal to the solubility of pyrene in water at 22°C. 16 The mixtures were sonicated for 30 min in an ultrasonic bath and shaken in a shaking air bath for 1 h at room temperature. Pyrene emission spectra were obtained using a fluorescence spectrophotometer (Hitachi FL-4500, Japan). The probe was excited at 343 nm, and the emission spectra were recorded in the range of 350-500 nm at an integration time of 1.0 s. The excitation and emission slit opening were 10 and 2.5 nm, respectively.
Drug Loading Efficiency.
Drug-loaded hollow nanocapsules were prepared by dissolving 20 µg/mL of DOX in 20 mL acquired nanocapsule suspension before ultrasonication. Insoluble, free DOX was removed by centrifugation at 2000 rpm and 4°C for 5 min. The drug-containing nanocapsules were then separated from the aqueous solution by centrifugation at 15 000 rpm and 4°C for 15 min. Drug concentration in the supernatant was analyzed by ultraviolet absorption (UV) at wavelength of 490 nm, a strong absorption band of DOX, with reference to a calibration curve on a UV-vis spectrometer (SP-8001, Metertech Inc.). The measurements were performed in triplicate. The amount of the drug in the hollow nanocapsules could be calculated by the total amount of DOX subtracting the residual DOX in the supernatant. The encapsulation efficiency (EE) was obtained as follows:
where A is the total amount of the DOX, B is the amount of DOX remaining in the supernatant, and C is the weight of the nanocapsules.
2.7. DOX Release. A solution of DOX or DOX-loaded nanocapsules (∼20 µg/mL DOX equiv) was added to a Slid-A-Lyzer dialysis cassette (Pierce) with a molecular weight cutoff of 10 000. The solution was dialyzed at 37°C against 0.1 M 100 mL buffer solution. The solution was removed periodically from the dialysis cassette and characterized using an absorbance at a wavelength of 490 nm to determine the amount of DOX in the solution, and then the solution was poured back to the dialysis cassette.
Results and Discussion
3.1. Formation of CHC Nanoaggregates. The molecular structure of CHC is given in Figure 1 , and CHC samples with various degrees of hexanoyl substitution (DH) were confirmed by 1 H NMR analysis 15 as given in Table 1 . After dispersing in water, the CHC conjugates formed self-assembled nanometric aggregates by ultrasonication. The fluorescence probe technique was used to investigate the self-aggregation behavior of the CHC at a molecular level, and pyrene was chosen as a fluorescence probe. Pyrene shows only small fluorescence intensity in a polar environment (such as water) due to its poor solubility and selfquenching, but strongly emits when the hydrophobic microdomains are formed in an aqueous solution because the pyrene molecules show high affinity to these hydrophobic microdomains. Therefore, pyrene is often used as a fluorescence probe to monitor the self-aggregation behavior of surfactants and/or polymers. 17 In addition, the intensity ratio of the first peak (372 nm) and the third peak (385 nm), I 372 /I 385 , in its fluorescent spectrum is quite sensitive to the environment surrounding the pyrene molecules and has been frequently used as an indicator for a subtle change of its environment. Hence, the critical aggregation concentration (cac), which is defined as the threshold concentration of self-aggregate formation by intraand /or intermolecular association, can be determined from the change of the I 372 /I 385 value of pyrene in the presence of polymeric amphiphiles. (1.72) of pyrene in water at low concentrations 18 and then followed by a linear decrease with further increasing concentration. The cac can then be determined by the intercept of two straight lines. 19 It was found that the CHC-4 composition demonstrated the lowest cac, i.e., 0.004 mg/mL, among the others and is lower than the critical micelle concentration of many low-molecular-weight surfactants reported, e.g., sodium dodecyl sulfate. 20 Accordingly, this finding suggests that the CHC nanoaggregates prepared in this work should be thermodynamically stable in aqueous solution, and this has been further evidenced by the fact that those nanocapsules exhibited excellent colloidal stability in PBS over a long-term storage for at least 1 month in refrigerator.
However, for CC, the I 372 / I 385 values decreased slightly only at high concentration (0.25 mg/mL), indicating difficulty for the CC molecules to aggregate in the studied range of concentration. Moreover, since from Table 2 the cac values of the CHC nanoaggregates were decreased with the increase of DH; it can thus be deduced from the observation of the self-aggregate ability between CC and CHC that the aggregation of CHC in water was due to the incorporation of hydrophobic groups by increasing the degree of hexanoyl substitution. It was known that the increase of hydrophobicity in amphiphatic polymer causes the difficulty to dissolve in aqueous solution because the energy is essential to cut the H-bonding in water molecules (need to do work). Therefore, the dissolution of hydrophobic groups in water would result in the increase of the surface free energy. In order to decrease the energy, the hydrophobic groups trend to aggregate. Hence, CHC-4, having the highest DH, is able to form nanoaggregates at a very low concentration (e.g., 0.004 mg/mL) because increase of the resulting surface energy is the greatest. On the contrary, for CC with the least hydrophobicity, the required concentration to form nanoaggregates is much higher (e.g., 0.25 mg/mL) than that of the CHC. This appears to indicate that the self-aggregate ability can be effectively enhanced with increasing hydrophobic nature of the modified chitosan in an aqueous environment.
The zeta potentials of the resulting CHC self-aggregated nanoparticles in water were determined and showed to be negatively charged ( Table 2 ), suggesting that the negatively charged carboxymethyl groups in the CHC molecules were mainly distributed on the outer surface of the nanoparticles contributing to the hydrophilic potential. The absolute value of the zeta potential of the CHC nanoparticles decreased from 42.8 to 23.1 mV with DH increasing from 0 to 0.48, as shown in Figure 3 . The change of the zeta potential (or surface charge) of the CHC nanoparticles is rapid while the substitution is below 0.26; however, it turns out to reach a plateau stage with further increase in the DH level over 0.33, suggesting the addition of the hexanoyl group may reach a level of saturation. The sharp decrease of the zeta potential from -38.4 to -27.5 mV when the DH is increasing from 0.13 to 0.26 suggests a reduction, albeit not significant, of the electrostatic repulsion, which, as a consequence, may cause gradual agglomeration of the CHC molecules to form larger particles while dispersing in water. Figure 4 shows the transmission electron microscopy (TEM) images of the CHC nanoaggregates. The nanoaggregates show a perfect spherical geometry and have a size ranging from 20 to100 nm with increase of DH. In contrast, the self-assembled CC nanoaggregates (Figure 4a) show a relatively uniform size distribution of around 20 nm in diameter. While increasing the DH to 0.48 (CHC-4), it was found that the size of nanoaggregate is increased to around 100 nm, as depicted in Figure 4b . In addition, the mean size of the CHC nanoaggregates measured by dynamic light scattering (DLS) exhibits two size groups, as listed in Table 2 : one corresponds to smaller particle size of around 40 nm (i.e., mean size 1), and the other is larger particle size of around 200 nm (mean size 2). The smaller particle size may be caused by the coil of the CHC single chain in the solution. 21 However, with increase of DH, the enhanced hydrophobic interaction and, in the meantime, reduced intermolecular repulsive force both facilitate self-aggregation, thus increasing the size of the aggregates. Such a bimodal size distribution of the CHC nanoparticle suggests that the nanoaggregates formed simultaneously by the coil of the CC single chain and/or by the hydrophobic interaction among CHC macromolecules in the solution. It was obtained from Figure 5 that the CC shows a high fraction (>90%) of the nanoaggregates having a size of 40 nm, suggesting that it is difficult to form larger aggregate with lower degree of hydrophobic substitution (i.e., DH < 0.13). However, as DH increased up to 0.26, the nanoaggregates show a high fraction of mean size 2 (around 200 nm), indicating that a critical concentration of hexanoyl substitution in the range between 0.13 and 0.26 dominates the self-assemble behavior of the CHC macromolecules.
Nanostructural Development of the CHC Nanoaggregates.
In Figure 6a , the hexanoyl-modified carboxymethyl chitosan has the amphiphilic property with hydrophile and hydrophobe. On the basis of the polycore model proposed by Wang et al., 22 for hydrophobically modified polysaccharides, the hydrophobic microdomains are formed by the association of hydrophobic group, and the polysaccharide backbones coil to form the hydrophilic shells outside these hydrophobic microdomains; thus, a minimal energy state is attained in aqueous media. For CC and CHC-1, the hydrophobic interaction provides the driving force for self-aggregation as supported to be a combination of the effects of intermolecular H-bonding of CC (e.g., the presence of carboxylic, hydroxyl, and amino groups on the CC chains); electrostatic repulsions between COOgroups on the CC chains and hydrophobic interaction among the hydrophobic moieties in CC such as acetyl groups and glucosidic rings. 10 Hence, for the CHC with lower DH, the particle-like aggregated structure of CHC was formed. However, from a recent investigation using hydrophobic acyl group of various carbon lengths, we found that a structural change from particle to hollow capsule with increasing the DH of CHC was strongly affected by the variation of the physical state of water molecules within the aggregates (submitted in press). Accordingly, the increase of bound water within CHC matrix with increasing DH enhances difficulty in the formation of hydrophobic core and becomes structurally unstable. In contrast, with increase of free energy caused by increasing hydrophobicity, the CHC tends to self-aggregate to form a bilayer structure with hydrophilic-hydrophobic-hydrophilic configuration, as schematically illustrated in Figure 6b . 23 The amphiphilic potential of the CHC with higher DH is then thermodynamically favorably to drive the resulting CHC macromolecules to selfassemble into a bilayer structure with water molecules encapsulated inside the core phase while both interior and exterior regions of the shell are stabilized by the hydrophilic groups, forming a spherical architecture with minimal surface energy, as schematically shown in Figure 6c .
However, an increase in entropy change due to the formation of nanoaggregate in aqueous environment has to be compromised thermodynamically. Although there are little evidence or supports that are available in the literature in similar materials systems, an alternative mechanism proposed by Moroi 24 appears feasible. Moroi involved the peculiar properties of water by recognizing that the water molecules in the liquid state have a structure of hydrogen bonds similar to that of ice; the cavities in the structure are large enough to accommodate a hydrophobic group, such as a hydrocarbon chain. Thus, occupation of a cavity by hydrophobic solute hinders the movement of free water molecules, which therefore remain stationary for longer periods, i.e., improved stability of the colloidal system. In order words, the water molecules surrounding a hydrophobic solute become more ordered than bulk water molecules and have lower entropy. Accordingly, the water molecules become more ordered around the hydrophobic solute with an increase in hydrophobicity in order to accommodate the variation of system entropy while the nanoaggregates were underdeveloping.
Though the morphology of the nanoaggregates show spherical shape from TEM results, the scanning electron microscopy (SEM) images show entirely different morphologies of the nanoaggregates, as shown in Figure 7 , where the nanoaggregates displayed collapsed structures. This variation is mainly caused by the difference of the preparation methods. For TEM sample preparation, the CHC aggregates are subjected to ambient drying, where the excellent water absorption and water retention capability, especially the crystal water binding with the molecular structure keep the CHC nanoaggregate its structural integrity. However, when the water, i.e., both free water (i.e., unbound water) and crystal water (i.e., bound water) being removed from the CHC macromolcules using ethanol through extensive dehydration, structural integrity of the nanoaggregates can no longer preserve. It collapsed as a flatten basketball. This morphological change suggests a hollow structure evolved upon the first formation of the CHC nanoaggregates (Figure 6d) , indicating a capsule-like nanostructure, where a core-shell configuration developed. From the collapsed morphology, the thickness of the shell layer of the collapsed nanocapsules, from the image inserted in Figure 7 (a combination of two shells of the nanocapsule) is about 9 nm; the layer thickness of the single shell is ca. to be 4.5 nm. Such a small scale of the shell thickness may explain the reason that the core-shell structure of the CHC nanocapsules is hard to distinctly differentiate from TEM analysis under the resolution aforementioned.
DOX Loading and Release
Behavior of CHC Nanocapsules. To investigate the drug-loading capacity of the CHC nanocapsules, the model drug, doxorubicin (DOX), was loaded into the CHC nanocapsules. Figure 8a shows the encapsulation efficiency (EE) of DOX from CHC nanocapsules with different DH. As reported by Kitaeva et al., 25 since DOX molecule contains an amino group with a pK a of 8.6, it is expected that DOX can form polyelectrolyte complex with the carboxymethyl groups of CC and CHC. Hence, for the CC (where its DH is zero), it shows a lower encapsulation efficiency of around 26.3%. However, as increase the level of hydrophobic substitution, the DOX encapsulation efficiency increased from 26.3 to 46.8% as the DH increased form 0 to 0.48. The improved encapsulation efficiency with increase of DH of the CHC should be caused by the larger reservoir space and the increase of the hydrophobic interaction of inner shell, which restricts the outward diffusion of DOX from nanocapsules.
The release of DOX from the CHC nanocpasules was investigated using a dialysis procedure. A solution of the DOXloaded CHC nanocapsules in a dialysis cassette was dialyzed against 100 mM buffer, and the solution in the cassette was sampled at various times over a 7 day period to determine the amount of DOX remaining in the nanocapsules. Figure 8b shows the release profiles of DOX and DOX-loaded CHC nanocapsules with different levels of DH. It was observed that DOX and DOX-loaded CC had a faster diffusion rate with essentially complete release after 24-36 h. This is consistent with the expected rate of diffusion for low molecular weight molecules across the dialysis membrane. However, DOX-loaded CHC nanocapsules show a two-step release profile. In the first step (0-12 h), the rapid release of DOX may caused by the diffusion of DOX on the surface of nanocapsules out of the dialysis membrane. Then, the followed a relatively slow release, which may be dominated by the DH of CHC nanocapsules. It can be found that CHC-1 showed a total release period of about 96 h. By contrast, with the increase of DH (i.e., CHC-2, CHC-3, and CHC-4), the entrapped DOX showed a continuous release over 7 days. It is reasonably believed that the increase of hydrophobic groups enhances encapsulation efficiency and payload of the DOX within CHC nanocapsules. These results indicate that these CHC self-assembled hollow nanocapsules can be a suitable candidate for controlled DOX delivery for anticancer purposes.
Conclusion
In present study, we demonstrated a simple and direct method that amphiphilic CHC hollow nanocapsules were developed in aqueous system without the aid of surfactants, organic solvents, emulsion phases, or template cores. In addition, the particle size, surface charge, and critical aggregation concentration (cac) of the CHC self-assembled hollow nanocapsules with different degree of hydrophobic substitution were systematically investigated. The results of SEM and TEM proved that the selfassembled CHC nanocapsules exhibited spherical morphology and a core-shell configuration. The formation of CHC selfassembled hollow nanocapsules is due to the hydrophobic interactions of hexanoyl groups in aqueous solution, and the negatively charged carboxymethyl groups also play an important role in the morphology and the stability of nanocapsules. The loading of doxorubicin drug can be improved by increase of DH for a sustained release over a reasonable period of time. 
